Dextromoramide

Dextromoramide
Clinical data
Trade namesPalfium
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • AU: C
Routes of
administration
Oral, Rectal, Intravenous, Insufflation[1]
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability>75%[3]
Protein bindingHigh[3]
MetabolismLiver, partly mediated by CYP3A4[3]
Elimination half-life3.5 hours[3]
ExcretionUrine, faeces[3]
Identifiers
  • (3S)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-yl-butan-1-one
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.006.013 Edit this at Wikidata
Chemical and physical data
FormulaC25H32N2O2
Molar mass392.543 g·mol−1
3D model (JSmol)
  • C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1
  • InChI=1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3/t21-/m1/s1 checkY
  • Key:INUNXTSAACVKJS-OAQYLSRUSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Dextromoramide[4] (Palfium, Palphium, Jetrium, Dimorlin)[5] is a powerful opioid analgesic approximately three times more potent than morphine but shorter acting.[6] It is subject to drug prohibition regimes, both internationally through UN treaties and by the criminal law of individual nations, and is usually prescribed only in the Netherlands.

  1. ^ Brayfield A, ed. (13 December 2013). "Dextromoramide". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 23 April 2014.
  2. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  3. ^ a b c d e "SAMENVATTING VAN DE PRODUCTKENMERKEN" (PDF). ACE Pharmaceuticals website (in Dutch). ACE Pharmaceuticals. January 2002. Retrieved 23 April 2014.[permanent dead link]
  4. ^ GB Patent 822055 Improvements in or relating to new analgesically active substituted alpha, alpha-diphenyl--y-amino-butyramides and the manufacture thereof
  5. ^ GB Patent 822055
  6. ^ Twycross RG, Lack SA (1989). Oral morphine in advanced cancer (2nd ed.). Beaconsfield. ISBN 978-0-906584-27-9.